The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Proto-oncogene HRAS transcript level and overall survival in stage II and III colorectal cancer.
 
Donghyun Kim
No Relationships to Disclose
 
Saima Sharif
Research Funding - GlaxoSmithKline
 
Juan Antonio Raygoza Garay
No Relationships to Disclose
 
Michelle Churchman
No Relationships to Disclose
 
Robert Rounbehler
No Relationships to Disclose
 
Avinash Bhakta
No Relationships to Disclose
 
Patrick Boland
Consulting or Advisory Role - BeiGene; Bristol Myers Squibb Foundation; Taiho Oncology
Research Funding - Caris Life Sciences (Inst); Compass Therapeutics (Inst); MEI Pharma (Inst); Merck (Inst); Processa Pharmaceuticals (Inst)
 
Michael Cavnar
No Relationships to Disclose
 
Hassan Hatoum
Consulting or Advisory Role - Foundation Medicine
 
Lyen Huang
No Relationships to Disclose
 
Joseph Kim
Research Funding - Exelixis (Inst); Ipsen (Inst); Merck (Inst)
 
Richard Kim
Honoraria - Natera
Consulting or Advisory Role - Abbvie; AstraZeneca; Bayer; Eisai; Exelixis; Jazz Pharmaceuticals; Pfizer; Roche/Genentech; SERVIER; Taiho Oncology
Speakers' Bureau - AstraZeneca; Incyte
 
Robert Lentz
Consulting or Advisory Role - Agenus (Inst); Boehringer Ingelheim (Inst); Merck (Inst); Natera (Inst)
Research Funding - ALX Oncology (Inst); AstraZeneca (Inst); Boehringer Ingelheim (Inst); Experimental Drug Development Centre (EDDC)/A*STAR (Inst); Guardant Health (Inst); Lilly (Inst); Merck (Inst)
 
Sarbajit Mukherjee
Consulting or Advisory Role - BeiGene; Eisai; Merck
Research Funding - Ipsen (Inst)
Other Relationship - Esophageal Cancer Action Network (ECAN)
 
Mary O'Donnell
No Relationships to Disclose
 
Benjamin Quartey
No Relationships to Disclose
 
Matthew Reilley
Consulting or Advisory Role - Pfizer; Seattle Genetics/Astellas
Research Funding - AstraZeneca (Inst); Cardiff Oncology (Inst); Macrogenics (Inst); Merck (Inst); Pfizer (Inst); Surface Oncology (Inst); Takeda (Inst); Xencor (Inst); ZielBio (Inst)
 
Bodour Salhia
Leadership - CpG Diagnostics
Stock and Other Ownership Interests - CpG Diagnostics Inc
Consulting or Advisory Role - AstraZeneca
Patents, Royalties, Other Intellectual Property - Patents filed and pending at University of Southern California
(OPTIONAL) Uncompensated Relationships - CpG Diagnostics
 
Bryan Schneider
Honoraria - Lilly
Research Funding - Foundation Medicine; Genentech/Roche; Pfizer
 
Carlos Chan
No Relationships to Disclose